This study is currently not recruiting participants.

A Prospective, Multicenter, Double-Blind, Sham-Controlled Study to Confirm the Safety and Efficacy of s-TMS in Treatment of Major Depressive Disorder

A Prospective, Multicenter, Double-Blind, Sham-Controlled Study to Confirm the Safety and Efficacy of s-TMS in Treatment of Major Depressive Disorder
Not Recruiting
18 years - 70 years
All
Phase N/A
1 Location

Brief description of study

This study is a multicenter, randomized, double-blind, sham-controlled trial to confirm the safety and efficacy of NEST sTMS device in treatment of subjects with major depressive disorder who have not responded to at least one antidepressant treatment.

Detailed description of study

Patients who decide to participate in this study will be randomized to either receive the active or simulated (sham) treatment. Synchronized transcranial magnetic stimulation (sTMS) is a non-invasive method for stimulating cells in your brain using magnetic fields generated by magnetic coils placed near your head. The study duration is 6 weeks for 5 daily study treatment sessions per week, for a total of 30 study treatments. Following completion of all study treatments, you may be eligible for an additional 6 weeks of treatment with active sTMS therapy. The study treatment and all tests, procedures and visits required by the study are provided at no cost to you.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Mitral Valve Insufficiency,,mitral valve insufficiency
  • Age: 18 years - 70 years
  • Gender: All
Updated on 19 Feb 2024. Study ID: NND-3002

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.